IFN-I, IRF7 and ISGs are highly expressed in the oropharyngeal cells of SARS-CoV-2-positive patients (142), and strong IFN- I responses in patients with severe COVID-19 (143), for IFN- I may aggravate TNF- and IL-1-driven inflammation. The gene discussed is IRF7; the disease is COVID-19.